Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Weatherald

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Chest|March 27, 2026
A Randomized, Placebo-Controlled, Double-Blind, Crossover Trial of Inhaled Nitric Oxide in Patients With Mild-to-Severe COPDSophie É Collins, Miranda Kirby, Benjamin M Smith, et al.
The European Respiratory Journal|July 18, 2020
Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systemsMitja Jevnikar, David Montani, Laurent Savale, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|June 9, 2026
New and persistent psychoactive medication use in intensive care unit survivors with COVID-19: a multicentre population-based cohort studyAndrea C Shysh, Finlay A McAlister, Luan Manh Chu, et al.
Circulation|October 27, 2017
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial HypertensionJason Weatherald, Athénaïs Boucly, Denis Chemla, et al.
The European Respiratory Journal|October 12, 2018
Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell diseaseMatthieu Turpin, Christelle Chantalat-Auger, Florence Parent, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 29, 2022
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trialJason Weatherald, Mitesh V Thakrar, Rhea A Varughese, et al.
Chest|November 23, 2019
Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in FranceEric Hachulla, David Launay, Athénaïs Boucly, et al.
CJC Open|July 27, 2023
Association Between the Pulmonary Artery Pulsatility Index and Prognosis in Pulmonary Arterial Hypertension: A Multicentre StudySam Ostad, Jordan Sugarman, Abdullah Alkhodair, et al.
The European Respiratory Journal|August 5, 2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
Physiotherapy Canada. Physiotherapie Canada|March 11, 2024
"I Had to Know About It, I Had to Find It, I Had to Know How to Access it": Experiences of Access to Rehabilitation Services Among People Living with Long COVIDPam Hung, Katelyn Brehon, Maxi Miciak, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Chest|March 27, 2026
A Randomized, Placebo-Controlled, Double-Blind, Crossover Trial of Inhaled Nitric Oxide in Patients With Mild-to-Severe COPDSophie É Collins, Miranda Kirby, Benjamin M Smith, et al.
The European Respiratory Journal|July 18, 2020
Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systemsMitja Jevnikar, David Montani, Laurent Savale, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|June 9, 2026
New and persistent psychoactive medication use in intensive care unit survivors with COVID-19: a multicentre population-based cohort studyAndrea C Shysh, Finlay A McAlister, Luan Manh Chu, et al.
Circulation|October 27, 2017
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial HypertensionJason Weatherald, Athénaïs Boucly, Denis Chemla, et al.
The European Respiratory Journal|October 12, 2018
Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell diseaseMatthieu Turpin, Christelle Chantalat-Auger, Florence Parent, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 29, 2022
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trialJason Weatherald, Mitesh V Thakrar, Rhea A Varughese, et al.
Chest|November 23, 2019
Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in FranceEric Hachulla, David Launay, Athénaïs Boucly, et al.
CJC Open|July 27, 2023
Association Between the Pulmonary Artery Pulsatility Index and Prognosis in Pulmonary Arterial Hypertension: A Multicentre StudySam Ostad, Jordan Sugarman, Abdullah Alkhodair, et al.
The European Respiratory Journal|August 5, 2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
Physiotherapy Canada. Physiotherapie Canada|March 11, 2024
"I Had to Know About It, I Had to Find It, I Had to Know How to Access it": Experiences of Access to Rehabilitation Services Among People Living with Long COVIDPam Hung, Katelyn Brehon, Maxi Miciak, et al.
Pageof 16